Clarenta

Beyond's analysis on Clarenta

• 2026-10-01 — Clarenta acquires majority stake in Leads To Development to boost early‑stage drug development capabilities

Recent news mentioning Clarenta

• 2026-10-01 — Leads To Development se une a Clarenta Group
• 2026-10-01 — Le groupe Clarenta accueille Leads To Development pour renforcer ses compétences en matière de développement de médicaments au stade précoce
• 2026-09-30 — Leads To Development Joins Clarenta Group, Strengthening Early-Stage Drug Development Expertise

Appears alongside

• Leads To Development

Browse the full archive →